Back
Arrowhead Pharmaceuticals 10K Form
Sell
50
ARWR
Arrowhead Pharmaceuticals
Last Price:
21.51
Seasonality Move:
72.88%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ARWR News And Ratings
See the #1 stock for the next 7 days that we like better than ARWR
ARWR Financial Statistics
Sales & Book Value
| Annual Sales: | $240.74M |
|---|---|
| Cash Flow: | $-129.87M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $2.66 |
| Price / Book: | 8.26 |
Profitability
| EPS (TTM): | -4.66000 |
|---|---|
| Net Income (TTM): | $-538.64M |
| Gross Margin: | $0 |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Arrowhead Pharmaceuticals Earnings Forecast
Key Arrowhead Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 20 years for ARWR is 0.00%.
- The Selling, General & Administrative Expenses for ARWR have been equal to 37.77% of Gross Profit Margin.
- The Research & Development expenses have been 146.71% of Revenue.
- The Interest Expense is -8.93% of Operating Income.
- The Net Earning history of ARWR is -85.27% of Total Revenues.
- Per Share Earnings over the last 27 years have been positive in 12 years.
Arrowhead Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ARWR |
| CUSIP: | 04280A |
| Website: | arrowheadpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
ARWR Technical Analysis vs Fundamental Analysis
Sell
50
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy or a Sell?
-
Arrowhead Pharmaceuticals stock is rated a Sell
The current Arrowhead Pharmaceuticals [ARWR] share price is $21.95. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.